Open AccessErythropoietin protects the systolic function of neonatal hearts against ischaemia/reperfusion injury
Author(s) -
Karlos Alexandre Sousa Vilarinho,
P. P. M. de Oliveira,
Mário J.A. Saad,
Pirooz Eghtesady,
Lindemberg Mota Silveira Filho,
R. W. Vieira,
Orlando Petrucci
Publication year - 2012
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezs254
Subject(s) - cardiology , reperfusion injury , ischemia , medicine , erythropoietin
The effect of erythropoietin (EPO) on neonatal hearts is not well understood. The current hypothesis is that EPO has protective effects against ischaemia-reperfusion when administered prior to ischaemia induction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom